SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-21-000038
Filing Date
2021-05-10
Accepted
2021-05-10 16:08:09
Documents
76
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q halo-20210331.htm   iXBRL 10-Q 1391689
2 EX-31.1 ex31110qq12021.htm EX-31.1 13055
3 EX-31.2 ex31210qq12021.htm EX-31.2 12980
4 EX-32 ex3210qq12021.htm EX-32 13875
10 halo-20210331_g1.jpg GRAPHIC 461748
11 halo-20210331_g2.jpg GRAPHIC 90443
  Complete submission text file 0001159036-21-000038.txt   8272707

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20210331.xsd EX-101.SCH 39956
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20210331_cal.xml EX-101.CAL 90201
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20210331_def.xml EX-101.DEF 230804
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20210331_lab.xml EX-101.LAB 526598
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20210331_pre.xml EX-101.PRE 377565
12 EXTRACTED XBRL INSTANCE DOCUMENT halo-20210331_htm.xml XML 1203129
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 21907208
SIC: 2836 Biological Products, (No Diagnostic Substances)